Nanocarriers for Targeted Therapy and Management of Liver Cancer
- 1st Edition - March 1, 2027
- Latest edition
- Editors: Devesh U. Kapoor, Bhupendra G. Prajapati, Nemat Ali
- Language: English
Nanocarriers for Targeted Therapy and Management of Liver Cancer presents a comprehensive academic overview of nanocarrier‑based strategies for addressing the biological, pharma… Read more
Description
Description
Nanocarriers for Targeted Therapy and Management of Liver Cancer presents a comprehensive academic overview of nanocarrier‑based strategies for addressing the biological, pharmacological, and translational challenges of liver cancer. The book positions nanomedicine as a critical enabler of targeted, safer, and more effective therapies for hepatocellular carcinoma and related malignancies. The volume systematically covers major nanocarrier platforms alongside emerging approaches such as AI‑assisted design, pharmacokinetic modeling, nanotoxicology, clinical translation, and regulatory considerations. Each chapter integrates foundational concepts with current research, clinical trial insights, and future outlooks to ensure coherence and academic rigor. For researchers and graduate‑level learners, the book provides an authoritative reference that bridges nanocarrier design, liver‑specific biology, and translational feasibility. It supports advanced study, interdisciplinary research, and informed innovation in precision nanomedicine for liver cancer.
Key features
Key features
- Integrates nanocarrier design principles with liver‑specific tumor biology and translational challenges
- Examines clinical trials, nanotoxicology, pharmacokinetics, and regulatory pathways alongside core technologies
- Highlights emerging tools such as AI‑assisted modeling, exosomes, and gene‑based nanotherapeutics
Readership
Readership
Graduate students, postdoctoral researchers, and academic scientists in oncology, nanomedicine, pharmaceutical sciences, biomedical engineering, and drug delivery, with secondary relevance for translational and regulatory researchers
Table of contents
Table of contents
1. Introduction to Liver Cancer and Nanocarrier Based Therapeutics
2. Liposomes as Nanocarriers for Liver Cancer Therapy
3. Solid Lipid Nanoparticles for Liver Cancer
4. Polymeric Nanoparticles for Liver Cancer Management
5. Polymeric Micelles for Targeted Hepatic Delivery
6. Dendrimers as Nanoscale Delivery Systems
7. Mesoporous Silica Nanoparticles for Liver Cancer Therapy
8. Metallic Nanoparticles in Liver Cancer Management
9. Carbon Based Nanocarriers in Hepatic Oncology
10. Hydrogel Based Nanocarriers for Localized Liver Cancer Therapy
11. Exosomes and Biomimetic Nanocarriers
12. Artificial Intelligence in Nanocarrier Design and Liver Cancer Management
13. Clinical Translation, Nanotoxicology, and Trials of Nanocarriers
14. Pharmacokinetics, Pharmacodynamics, and AI Assisted Modeling
15. Regulatory Pathways, QbD, and Manufacturing Scale Up
16. Gene and Nucleic Acid Based Nanocarrier Delivery Systems
2. Liposomes as Nanocarriers for Liver Cancer Therapy
3. Solid Lipid Nanoparticles for Liver Cancer
4. Polymeric Nanoparticles for Liver Cancer Management
5. Polymeric Micelles for Targeted Hepatic Delivery
6. Dendrimers as Nanoscale Delivery Systems
7. Mesoporous Silica Nanoparticles for Liver Cancer Therapy
8. Metallic Nanoparticles in Liver Cancer Management
9. Carbon Based Nanocarriers in Hepatic Oncology
10. Hydrogel Based Nanocarriers for Localized Liver Cancer Therapy
11. Exosomes and Biomimetic Nanocarriers
12. Artificial Intelligence in Nanocarrier Design and Liver Cancer Management
13. Clinical Translation, Nanotoxicology, and Trials of Nanocarriers
14. Pharmacokinetics, Pharmacodynamics, and AI Assisted Modeling
15. Regulatory Pathways, QbD, and Manufacturing Scale Up
16. Gene and Nucleic Acid Based Nanocarrier Delivery Systems
Product details
Product details
- Edition: 1
- Latest edition
- Published: March 1, 2027
- Language: English
About the editors
About the editors
DK
Devesh U. Kapoor
Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs.
Affiliations and expertise
Dr. Dayaram Patel Pharmacy CollegeBP
Bhupendra G. Prajapati
Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination.
Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, IndiaNA
Nemat Ali
Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.
Affiliations and expertise
Assistant Professor, Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia